These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 34310645)
1. The influence of LncRNA H19 polymorphic variants on susceptibility to cancer: A systematic review and updated meta-analysis of 28 case-control studies. Wang K; Zhu Z; Wang Y; Zong D; Xue P; Gu J; Lu D; Tu C PLoS One; 2021; 16(7):e0254943. PubMed ID: 34310645 [TBL] [Abstract][Full Text] [Related]
2. Association between lncRNA H19 polymorphisms and cancer susceptibility based on a meta-analysis from 25 studies. Liu C; Chen L; You Z; Wu Y; Wang C; Zhang G; Xu B; Chen M Gene; 2020 Mar; 729():144317. PubMed ID: 31884107 [TBL] [Abstract][Full Text] [Related]
3. Association between genetic polymorphisms of long noncoding RNA H19 and cancer risk: a meta-analysis. Hashemi M; Moazeni-Roodi A; Sarabandi S; Karami S; Ghavami S J Genet; 2019 Sep; 98():. PubMed ID: 31544800 [TBL] [Abstract][Full Text] [Related]
4. Association of lncRNA H19 polymorphisms with cancer susceptibility: An updated meta-analysis based on 53 studies. Yuan Y; Wang Y; Niu X; Han Y; Li W; Cheng M; Li Z; Tan J; Zhao Y; Wang W Front Genet; 2022; 13():1051766. PubMed ID: 36588790 [TBL] [Abstract][Full Text] [Related]
5. Significant association between long non-coding RNA H19 polymorphisms and cancer susceptibility: A PRISMA-compliant meta-analysis and bioinformatics prediction. Li W; Jiang X; Jin X; Yan W; Liu Y; Li D; Zhao Z Medicine (Baltimore); 2020 Apr; 99(15):e19322. PubMed ID: 32282694 [TBL] [Abstract][Full Text] [Related]
6. Significant association between lncRNA H19 polymorphisms and cancer susceptibility: a meta-analysis. Li XF; Yin XH; Cai JW; Wang MJ; Zeng YQ; Li M; Niu YM; Shen M Oncotarget; 2017 Jul; 8(28):45143-45153. PubMed ID: 28404885 [TBL] [Abstract][Full Text] [Related]
7. Six polymorphisms in the lncRNA H19 gene and the risk of cancer: a systematic review and meta-analysis. Yang M; Zhang M; Wang Q; Guo X; Geng P; Gu J; Ji W; Zhang L BMC Cancer; 2023 Jul; 23(1):688. PubMed ID: 37480014 [TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of polymorphisms in H19 lncRNA and cancer risk: a meta-analysis of 13,392 cases and 18,893 controls. Chu M; Yuan W; Wu S; Wang Z; Mao L; Tian T; Lu Y; Zhu B; Yang Y; Wang B; Gao H; Jiang L; Zhuang X Oncotarget; 2016 Nov; 7(48):78631-78639. PubMed ID: 27732938 [TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of lncRNA H19 polymorphisms and cancer risk: a meta-analysis based on 48,166 subjects. Liu X; Zhao Y; Li Y; Zhang J Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):15-27. PubMed ID: 31852249 [TBL] [Abstract][Full Text] [Related]
10. Relationship between Long Noncoding RNA H19 Polymorphisms and Risk of Coronary Artery Disease in a Chinese Population: A Case-Control Study. Hu WN; Ding HX; Xu Q; Zhang XY; Yang DT; Jin YZ Dis Markers; 2020; 2020():9839612. PubMed ID: 32454910 [TBL] [Abstract][Full Text] [Related]
11. The Relationship between Long Noncoding RNA H19 Polymorphism and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma. Wang YC; Tsao SM; Li YT; Lee CY; Tsao TC; Hsieh MJ; Yang SF Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33799753 [TBL] [Abstract][Full Text] [Related]
12. Association of genetic variants in lncRNA H19 with risk of colorectal cancer in a Chinese population. Li S; Hua Y; Jin J; Wang H; Du M; Zhu L; Chu H; Zhang Z; Wang M Oncotarget; 2016 May; 7(18):25470-7. PubMed ID: 27027436 [TBL] [Abstract][Full Text] [Related]
13. Association between long non-coding RNA H19 polymorphisms and breast cancer risk: a meta-analysis. Li L; Huang Q; Yan F; Wei W; Li Z; Liu L; Deng J Women Health; 2022 Jul; 62(6):565-575. PubMed ID: 35818166 [TBL] [Abstract][Full Text] [Related]
14. Association between lncRNA-H19 polymorphisms and hepatoblastoma risk in an ethic Chinese population. Tan T; Li J; Wen Y; Zou Y; Yang J; Pan J; Hu C; Yao Y; Zhang J; Xin Y; Li S; Xia H; He J; Yang T J Cell Mol Med; 2021 Jan; 25(2):742-750. PubMed ID: 33236528 [TBL] [Abstract][Full Text] [Related]
15. Association between lncRNA H19 (rs217727, rs2735971 and rs3024270) polymorphisms and the risk of bladder cancer in Chinese population. Li Z; Niu Y Minerva Urol Nefrol; 2019 Apr; 71(2):161-167. PubMed ID: 29595036 [TBL] [Abstract][Full Text] [Related]
16. Association of lncRNA H19 rs217727 polymorphism and cancer risk in the Chinese population: a meta-analysis. Lu Y; Tan L; Shen N; Peng J; Wang C; Zhu Y; Wang X Oncotarget; 2016 Sep; 7(37):59580-59588. PubMed ID: 27486980 [TBL] [Abstract][Full Text] [Related]
17. The association of polymorphisms in lncRNA- Yang ML; Huang Z; Wang Q; Chen HH; Ma SN; Wu R; Cai WS Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29511035 [TBL] [Abstract][Full Text] [Related]
18. Associations between Hu C; Yang T; Pan J; Zhang J; Yang J; He J; Zou Y Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30890582 [No Abstract] [Full Text] [Related]
19. H19 gene polymorphisms and Wilms tumor risk in Chinese children: a four-center case-control study. Li W; Hua RX; Wang M; Zhang D; Zhu J; Zhang S; Yang Y; Cheng J; Zhou H; Zhang J; He J Mol Genet Genomic Med; 2021 Feb; 9(2):e1584. PubMed ID: 33403826 [TBL] [Abstract][Full Text] [Related]
20. LncRNA H19 polymorphisms associated with the risk of OSCC in Chinese population. Guo QY; Wang H; Wang Y Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3770-3774. PubMed ID: 28975993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]